Literature DB >> 19782383

Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiber.

John W Schoggins1, Erik Falck-Pedersen.   

Abstract

Adenovirus is a well-established viral gene transfer model system that presents two major hurdles when being considered for cell-specific targeting applications. First is the need to detarget the vector from inherent host binding mechanisms, and second is the need to establish a productive and stable method to retarget the vector to a desired cell receptor. In previous studies we had generated an adenovirus vector platform that lacks the normal targeting attributes derived from the fiber and penton capsid proteins. In the current study we characterized our detargeted Ad5-based vectors (Ad5.F7F41S and Ad5.F7F41SDeltaRGD) as platforms for novel retargeted viruses. The experimental strategy relied on incorporating small peptide ligands into several sites of the Ad 41short fiber knob domain (AB, CD, HI, G and Cterm). Reengineering of Ad41 short fiber resulted either in a bypass to fiber 7 usage, or in a dominant negative packaging/production deficiency phenotype. Under specific growth conditions we could remedy some of the capsid deficiencies and generate high titer viruses. However when examined by Western blot analysis, the resulting viruses were still defective in capsid content. The tandem fiber F7F41S platform has revealed an unanticipated sensitivity of Adenovirus packaging to fiber 41short structural modifications. These studies indicate fiber assembly into an intact virion or fiber influenced capsid stability as a bottleneck to efficient particle production. We also demonstrate that virus particles characterized as mature virions following CsCl banding can vary significantly in capsid protein content. Considering the complexity of virus entry into a target cell, modified "mature virions" may be compromised at the level of transduction not only through the intended modification, but also by virtue of secondary structural packaging conflicts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782383      PMCID: PMC2783338          DOI: 10.1016/j.virol.2009.08.041

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  47 in total

1.  alpha-Melanotropin: the minimal active sequence in the frog skin bioassay.

Authors:  V J Hruby; B C Wilkes; M E Hadley; F Al-Obeidi; T K Sawyer; D J Staples; A E de Vaux; O Dym; A M Castrucci; M F Hintz
Journal:  J Med Chem       Date:  1987-11       Impact factor: 7.446

2.  Regulation of the biosynthesis of subgroup C adenovirus protein IVa2.

Authors:  N Winter; J C D'Halluin
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Intermediates in adenovirus assembly.

Authors:  B Edvardsson; E Everitt; H Jörnvall; L Prage; L Philipson
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

4.  Characterization of adenovirus particles made by deletion mutants lacking the fiber gene.

Authors:  B Falgout; G Ketner
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

5.  Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber.

Authors:  A Novelli; P A Boulanger
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

6.  Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber.

Authors:  Takafumi Nakamura; Kenzo Sato; Hirofumi Hamada
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

7.  Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism.

Authors:  Karine Martin; Anne Brie; Patrick Saulnier; Michel Perricaudet; Patrice Yeh; Emmanuelle Vigne
Journal:  Mol Ther       Date:  2003-09       Impact factor: 11.454

8.  Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates.

Authors:  Theodore A G Smith; Neeraja Idamakanti; Jennifer Marshall-Neff; Michele L Rollence; Patrick Wright; Michele Kaloss; Laura King; Christine Mech; Lisa Dinges; William O Iverson; Alfred D Sherer; Judit E Markovits; Russette M Lyons; Michael Kaleko; Susan C Stevenson
Journal:  Hum Gene Ther       Date:  2003-11-20       Impact factor: 5.695

9.  Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo.

Authors:  John W Schoggins; Jason G D Gall; Erik Falck-Pedersen
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats.

Authors:  Campbell G Nicol; Delyth Graham; William H Miller; Stephen J White; Theodore A G Smith; Stuart A Nicklin; Susan C Stevenson; Andrew H Baker
Journal:  Mol Ther       Date:  2004-08       Impact factor: 11.454

View more
  1 in total

1.  Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds.

Authors:  Michael Behr; Johanna K Kaufmann; Patrick Ketzer; Sarah Engelhardt; Martin Mück-Häusl; Pamela M Okun; Gabriele Petersen; Frank Neipel; Jessica C Hassel; Anja Ehrhardt; Alexander H Enk; Dirk M Nettelbeck
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.